Dr. Nilesh Wasekar

Dr. Nilesh Wasekar – Hematologist

Dr. Nilesh Wasekar, a prominent hematologist, is presently affiliated with Ashoka Medicover Hospital, Parab Nagar in Nashik. With a decade of experience in hematology, he brings a wealth of expertise to his practice. Dr. Wasekar has served as an esteemed hematologist in various cities across India, showcasing his dedication to advancing the field. His tenure in the profession underscores his commitment to providing high-quality care and innovative solutions to his patients. 

Specialization

Dr. Nilesh Wasekar is a medical specialist in the following major interventions: 

1. Bone marrow transplantation
2. Haemato-Oncology
3. Lumbar puncture
4. Bone marrow aspiration and biopsy
5. Splenic aspirates
6. Insertion of central venous catheters
7. Phlebotomies and exchange transfusions

Expertise

Dr. Nilesh Wasekar has major expertise in the following areas –

Aplastic Anemia, Lymphomas (DLBCL, HCL Follicular, Mantle, SMZL, and T cell), Acute Leukemia(AML, ALL, CML, CLL, APML), Plasma cell disorders (Multiple Myeloma, WM), Myeloproliferative Neoplasm (Polycythemia, Myelofibrosis, ET), Immune Thrombocytopenia, SickleCell Disease, Bleeding disorders (Hemophilia, Von Wille brand Disease, Rare Bleeding Disorders), Thalassemia, recurrent Iron deficiency Anemia.

Education

• MBBS
• MD (Medicine)
• DM (Clinical Hematology) 

Career

• Full time Hemato-Oncologist at Ashoka Medicover Hospital, from April 2021
• Consultant Hematologist Global Hospital, Nov 2016-Feb 2017
• Assistant Professor KEM Parel from August 2015 to November 2016
• Senior Registrar Hematology KEM Parel from Aug 2012 to July 2015
• Assistant Professor Medicine JJH June 2008 to April 2011- Resident in Internal Medicine JJH from May 2011 to June 2012

Treatments

 Dr. Nilesh Wasekar specializes in the following treatments –

• Bone Marrow Transplant (BMT)

Fellowships

• Fellowship – hematopoietic stem cell transplantation

Publications

Dr. Nilesh Wasekar has authored more than 25 international and national publications. Some of the recent publications are mentioned below –

• Chorea is a rare manifestation of hyperglycemia. R Patil, N Wasekar, D Vishwanathan, SG Jadhav, VK Joglekar. The Journal of the Association of Physicians of India 61 (9), 663-664   

• Association of Helicobacter pylori infection with megaloblastic anemia: a single-center experience Nilesh Wasekar, Vinayak Wagaskar, Nalini Jadhav, Shailesh Jadhav. International Journal of Medical Science and Public Health   

• Clinical presentation and diagnosis of mucopolysaccharidosis type 2(Hunter syndrome). R Patil, N Wasekar, SG Jadhav, R Zore, P Sangoi, D Vishwanathan The Journal of the Association of Physicians of India 61 (8), 574-576

• Surgeries in patients with hemophilia: Experience from a comprehensive hemophilia care center of western India M Toshniwal, S Chandrakala, F Jijina, K Ghosh, N Wasekar*.HAEMOPHILIA 20, 86-8

• NILOTINIB INDUCED SKIN RASH IN CML PATIENT Dr. Aniket B. Mohite, Dr. Nilesh Wasekar*, Dr. Vinod P., Rajesh Patil, Shailesh Bamborde, and Chandrakala S.European Journal of Biomedical and Pharmaceutical Sciences   

• Nilotinib induced skin rash in chronic myeloid leukemia patients: A case series Nilesh Wasekar, Aniket B Mohite, S Chandrakala, P Vinod, P Rajesh, B Shailesh, Farah Jijina International Journal of Medical Science and Public Health

• Familial Hemophagocytic Lymphohistiocytosis (Fhl)-A Case Series P Kini, N Wasekar, RS Preetham Tauro, S Asangi, S Khude, S Jadhav Pediatric Hematology-Oncology Journal 3 (3), S16

• The Genes Speak-A Rare Case of Hemolytic Anemia! Sneha Fernandes, Pranoti Kini, Prabhakar Kedar, Punit Jain, Rashmi Dongerdiye, Nilesh Wasekar Pediatric Hematology-Oncology Journal [4:35 PM, 10/11/2021] AMH Vanita Marketing

Dr. Nilesh Wasekar’s dedication to advancing hematology in Nashik is commendable. His contributions are undoubtedly shaping the landscape of hematology in the country. It’s inspiring to see individuals like him making significant strides in their field, ultimately benefiting patients and the medical community alike.